Related Experiment Video
Updated: Jun 11, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
One Virus, Two Diseases: Evaluation of Clinical and Immunological Differences in Covid-19 and Multisystem
Sefika Ilknur Kokcu Karadag1, Emine Hafize Erdeniz2, Esra Ozkan3
1Department of Pediatric Allergy and Immunology, Ondokuz Mayis University Faculty of Medicine, Samsun, Türkiye.
Insights
Early detection of multisystem inflammatory syndrome in children (MIS-C) may involve identifying lymphopenia, increased B cells, and altered T cell profiles. These immunological markers can aid in distinguishing MIS-C from COVID-19 in pediatric patients.
Area of Science:
- Pediatric Immunology
- Infectious Diseases
- Clinical Diagnostics
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a serious condition linked to COVID-19.
- Early and accurate diagnosis of MIS-C is crucial for timely intervention and improved patient outcomes.
- Understanding the immunological differences between MIS-C and COVID-19 in children is essential for diagnostic development.
Purpose of the Study:
- To identify early immunological markers for the detection of MIS-C in children.
- To compare immunological profiles of MIS-C patients with those of pediatric COVID-19 patients.
- To explore potential diagnostic indicators for MIS-C through immunological analysis.
Main Methods:
- Retrospective analysis of immunological data from 33 MIS-C patients and 33 pediatric COVID-19 patients.
- Inclusion of 10 healthy children as controls.
- Comparison of complete blood counts, inflammatory markers, and lymphocyte subsets between groups.
Main Results:
- MIS-C patients exhibited more pronounced lymphopenia, thrombocytopenia, anemia, and neutrophilia compared to COVID-19 patients.
- Elevated ferritin, D-dimer, and C-reactive protein levels were observed in MIS-C patients.
- Increased B cell proportion, inverted CD4/CD8 ratio, and presence of active T cells (CD3+CD38+HLA-DR+) were significant findings in MIS-C.
Conclusions:
- Lymphopenia, increased B cells, reversed CD4/CD8 ratio, and active T cells are potential early diagnostic markers for MIS-C.
- These immunological findings may assist in differentiating MIS-C from COVID-19 in pediatric populations.
- Further research can validate these markers for routine clinical use in early MIS-C diagnosis.
Objectives:
This study aims to uncover early detection markers through the immunological analysis of children diagnosed with multisystem inflammatory syndrome (MIS-C) and coronavirus disease-2019 (COVID-19).
Methods:
We retrospectively analyzed immunological data from thirty-three MIS-C patients and an equivalent number of patients under the age of 18 with a positive polymerase chain reaction (PCR) test for COVID-19. These individuals were admitted to Ondokuz Mayis University between November 2020 and February 2021. In total, the study group consisted of 66 patients and an additional 10 healthy controls.
Results:
Lymphopenia, thrombocytopenia, anemia, and neutrophilia, along with elevated levels of ferritin, D-dimer, and C-reactive protein, were more pronounced in MIS-C patients (p<0.001). No significant disparities were found in serum IgG, A, M, and E concentrations. Notably, there was an increased proportion of B cells (p<0.001), an inversion of the CD4/CD8 ratio, and a marked presence of CD3+CD38+HLA-DR+active T cells (p=0.009) in the MIS-C cohort.
Conclusion:
In the early diagnosis of MIS-C, lymphopenia, increase in B cells, reversal of CD4/CD8 ratio, and demonstration of CD3+CD38+HLA-DR+active T cells may be helpful.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Investigation of Disease Outbreaks
Viral Meningitis
Coronavirus

